The direct costs of drug-induced skin reactions
Objective The aim of the study was an assessment of direct costs of patients hospitalised for for skin adverse drug reactions during 2002–2012 in the Department of Dermatology at the Military Institute of Medicine (Ministry of Defence) in Warsaw. The analysis was carried out from the perspectives of...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Institute of Rural Health
2017-05-01
|
Series: | Annals of Agricultural and Environmental Medicine |
Subjects: | |
Online Access: | http://www.journalssystem.com/aaem/The-direct-costs-of-drug-induced-skin-reactions,72543,0,2.html |
_version_ | 1818316681473163264 |
---|---|
author | Nina Kiepurska Elwira Paluchowska Witold Owczarek Monika Szkultecka – Dębek Karina Jahnz-Różyk |
author_facet | Nina Kiepurska Elwira Paluchowska Witold Owczarek Monika Szkultecka – Dębek Karina Jahnz-Różyk |
author_sort | Nina Kiepurska |
collection | DOAJ |
description | Objective
The aim of the study was an assessment of direct costs of patients hospitalised for for skin adverse drug reactions during 2002–2012 in the Department of Dermatology at the Military Institute of Medicine (Ministry of Defence) in Warsaw. The analysis was carried out from the perspectives of the public payer and service provider.
Material and Methods
The retrospective study was carried out in a group of 164 adult patients due to skin adverse drug reactions. Analysis was based on data from patient medical records and medical orders which provided information on the used resources, including diagnostic tests, medical consultations, medicinal products, hospitalisation duration, together with cost estimation, regardless of the treatment being the cause of the skin reaction.
Results
According to the International Statistical Classification of Diseases and Related Health Problems(ICD) diagnosis and scores, assigned by the National Healthcare Fund, it has been estimated that patient hospitalisation at the Department of Dermatology for skin drug reaction incurred costs at the average amount of €717.00 per patient. The complex diagnostics and pharmacotherapy of the same group of patients generated costs for the hospital at the average amount of €680 per patient.
Conclusions
As a result of the analysis, the therapy for skin adverse drug effects generates significant costs, both for the payer and the service provider. Since the costs are comparable, it seems that the pricing of medical procedures by the public payer is adequate for the costs incurred by the medical service provider. |
first_indexed | 2024-12-13T09:25:18Z |
format | Article |
id | doaj.art-c39aa8c178c644eb8f6bdcbb86a6e800 |
institution | Directory Open Access Journal |
issn | 1232-1966 1898-2263 |
language | English |
last_indexed | 2024-12-13T09:25:18Z |
publishDate | 2017-05-01 |
publisher | Institute of Rural Health |
record_format | Article |
series | Annals of Agricultural and Environmental Medicine |
spelling | doaj.art-c39aa8c178c644eb8f6bdcbb86a6e8002022-12-21T23:52:39ZengInstitute of Rural HealthAnnals of Agricultural and Environmental Medicine1232-19661898-22632017-05-0124219019310.5604/12321966.123516872543The direct costs of drug-induced skin reactionsNina Kiepurska0Elwira Paluchowska1Witold Owczarek2Monika Szkultecka – Dębek3Karina Jahnz-Różyk4Department of Dermatology, Military Institute of Medicine, Warsaw, PolandDepartment of Dermatology, Military Institute of Medicine, Warsaw, PolandDepartment of Dermatology, Military Institute of Medicine, Warsaw, PolandDepartment of Dermatology, Military Institute of Medicine, Warsaw, PolandDepartment of Immunology and Allergology, Military Institute of Medicine, Warsaw, PolandObjective The aim of the study was an assessment of direct costs of patients hospitalised for for skin adverse drug reactions during 2002–2012 in the Department of Dermatology at the Military Institute of Medicine (Ministry of Defence) in Warsaw. The analysis was carried out from the perspectives of the public payer and service provider. Material and Methods The retrospective study was carried out in a group of 164 adult patients due to skin adverse drug reactions. Analysis was based on data from patient medical records and medical orders which provided information on the used resources, including diagnostic tests, medical consultations, medicinal products, hospitalisation duration, together with cost estimation, regardless of the treatment being the cause of the skin reaction. Results According to the International Statistical Classification of Diseases and Related Health Problems(ICD) diagnosis and scores, assigned by the National Healthcare Fund, it has been estimated that patient hospitalisation at the Department of Dermatology for skin drug reaction incurred costs at the average amount of €717.00 per patient. The complex diagnostics and pharmacotherapy of the same group of patients generated costs for the hospital at the average amount of €680 per patient. Conclusions As a result of the analysis, the therapy for skin adverse drug effects generates significant costs, both for the payer and the service provider. Since the costs are comparable, it seems that the pricing of medical procedures by the public payer is adequate for the costs incurred by the medical service provider.http://www.journalssystem.com/aaem/The-direct-costs-of-drug-induced-skin-reactions,72543,0,2.htmladverse drug reactionsdirect costsICD 10JGPNational Health Fund |
spellingShingle | Nina Kiepurska Elwira Paluchowska Witold Owczarek Monika Szkultecka – Dębek Karina Jahnz-Różyk The direct costs of drug-induced skin reactions Annals of Agricultural and Environmental Medicine adverse drug reactions direct costs ICD 10 JGP National Health Fund |
title | The direct costs of drug-induced skin reactions |
title_full | The direct costs of drug-induced skin reactions |
title_fullStr | The direct costs of drug-induced skin reactions |
title_full_unstemmed | The direct costs of drug-induced skin reactions |
title_short | The direct costs of drug-induced skin reactions |
title_sort | direct costs of drug induced skin reactions |
topic | adverse drug reactions direct costs ICD 10 JGP National Health Fund |
url | http://www.journalssystem.com/aaem/The-direct-costs-of-drug-induced-skin-reactions,72543,0,2.html |
work_keys_str_mv | AT ninakiepurska thedirectcostsofdruginducedskinreactions AT elwirapaluchowska thedirectcostsofdruginducedskinreactions AT witoldowczarek thedirectcostsofdruginducedskinreactions AT monikaszkulteckadebek thedirectcostsofdruginducedskinreactions AT karinajahnzrozyk thedirectcostsofdruginducedskinreactions AT ninakiepurska directcostsofdruginducedskinreactions AT elwirapaluchowska directcostsofdruginducedskinreactions AT witoldowczarek directcostsofdruginducedskinreactions AT monikaszkulteckadebek directcostsofdruginducedskinreactions AT karinajahnzrozyk directcostsofdruginducedskinreactions |